GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $197,712,000 | -45.1% | 4,541,978 | -45.0% | 0.79% | -31.4% |
| Q1 2022 | $359,815,000 | -5.4% | 8,260,211 | -4.2% | 1.15% | -4.2% |
| Q4 2021 | $380,301,000 | +9.1% | 8,623,611 | -5.5% | 1.20% | +7.4% |
| Q3 2021 | $348,702,000 | -8.2% | 9,125,932 | -4.4% | 1.11% | -3.8% |
| Q2 2021 | $380,027,000 | +4.6% | 9,543,632 | -6.3% | 1.16% | +4.6% |
| Q1 2021 | $363,328,000 | -4.7% | 10,180,100 | -1.8% | 1.11% | -17.1% |
| Q4 2020 | $381,366,000 | +36.8% | 10,363,200 | +40.0% | 1.34% | +5.5% |
| Q3 2020 | $278,705,000 | -5.4% | 7,404,500 | +2.5% | 1.26% | -7.7% |
| Q2 2020 | $294,622,000 | +5.3% | 7,222,900 | -2.2% | 1.37% | -12.9% |
| Q1 2020 | $279,753,000 | -19.2% | 7,383,288 | +0.1% | 1.57% | +30.8% |
| Q4 2019 | $346,443,000 | +21.9% | 7,372,688 | +10.7% | 1.20% | +5.1% |
| Q3 2019 | $284,243,000 | -7.5% | 6,659,858 | -13.2% | 1.14% | -2.6% |
| Q2 2019 | $307,194,000 | +2.0% | 7,676,008 | +6.5% | 1.18% | -0.4% |
| Q1 2019 | $301,127,000 | +7.2% | 7,205,708 | -2.0% | 1.18% | -4.6% |
| Q4 2018 | $280,829,000 | -17.0% | 7,349,608 | -12.7% | 1.24% | +2.0% |
| Q3 2018 | $338,152,000 | +0.2% | 8,418,011 | +0.6% | 1.21% | -4.6% |
| Q2 2018 | $337,473,000 | +1.1% | 8,371,950 | -2.0% | 1.27% | -3.7% |
| Q1 2018 | $333,835,000 | +11.9% | 8,544,527 | +1.6% | 1.32% | +17.3% |
| Q4 2017 | $298,321,000 | -12.7% | 8,410,527 | -0.1% | 1.13% | -16.3% |
| Q3 2017 | $341,727,000 | +1.0% | 8,416,927 | +7.3% | 1.35% | -0.9% |
| Q2 2017 | $338,377,000 | +6.7% | 7,847,327 | +4.3% | 1.36% | +9.4% |
| Q1 2017 | $317,238,000 | +5.5% | 7,524,627 | -3.6% | 1.24% | +2.5% |
| Q4 2016 | $300,655,000 | -14.5% | 7,807,200 | -4.2% | 1.21% | -17.6% |
| Q3 2016 | $351,527,000 | -3.9% | 8,150,402 | -3.4% | 1.47% | -6.0% |
| Q2 2016 | $365,763,000 | +1.2% | 8,439,389 | -5.3% | 1.56% | +2.9% |
| Q1 2016 | $361,516,000 | -26.0% | 8,915,323 | -26.3% | 1.52% | -23.3% |
| Q4 2015 | $488,353,000 | +2.4% | 12,102,919 | -2.4% | 1.98% | +3.8% |
| Q3 2015 | $476,814,000 | -1.4% | 12,400,884 | +6.8% | 1.91% | +11.9% |
| Q2 2015 | $483,784,000 | -14.8% | 11,615,471 | -5.6% | 1.71% | -13.6% |
| Q1 2015 | $567,782,000 | +8.8% | 12,302,975 | +0.7% | 1.97% | +8.5% |
| Q4 2014 | $522,021,000 | +5.1% | 12,213,885 | +13.0% | 1.82% | +1.1% |
| Q3 2014 | $496,686,000 | +87.7% | 10,804,564 | +118.3% | 1.80% | +92.5% |
| Q2 2014 | $264,679,000 | +13369.7% | 4,949,118 | +13358.6% | 0.94% | +13257.1% |
| Q1 2014 | $1,965,000 | – | 36,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |